ArticleTransplantation direct2020
Impact of Postoperative Continuous Renal Replacement Therapy in Lung Transplant Recipients.
Article in Transplantation direct, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 31 citations in OpenAlex.
- Investigating an appropriate indicator of acute kidney injury for patient prognosis following lung transplantation.Renal failure · 2024Article
- Long-term survival and clinical outcomes of delayed chest closure following lung transplantation.Surgery today · 2024Article
- Thoracic and vertebral deformities in lung transplantation: perioperative complications and long-term prognoses.BMC pulmonary medicine · 2024Article
- COVID-19 pneumonia in lung transplant recipients: understanding risk factors and treatment outcomes in Japan.Clinical and experimental medicine · 2024Article
- Native-lung complications following single-lung transplantation for interstitial lung disease: an in-depth analysis.BMC pulmonary medicine · 2024Article
- Letermovir prophylaxis for cytomegalovirus in lung-transplant recipients: a comprehensive study with literature review of off-label use and real-world experiences.Clinical and experimental medicine · 2024Review
- Long-term management and outcome of lung transplantation in Japan.Journal of thoracic disease · 2023Review
- Roles of respirologists in lung transplantation in Japan: narrative review.Journal of thoracic disease · 2023Review
- Efficacy and safety of mRNA SARS-CoV-2 vaccines in lung transplant recipients.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2022Article
- Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis.BMC pulmonary medicine · 2021Article
- Recovery of physical function in lung transplant recipients with sarcopenia.BMC pulmonary medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute kidney injury (AKI) is a common complication after lung transplant (LTx), and continuous renal replacement therapy (CRRT) is increasingly of use to critically ill patients who have developed AKI. However, the optimal timing or threshold of kidney impairment for which to commence CRRT after LTx has been uncertain. There has also been limited information on the impact of CRRT among LTx recipients (LTRs) introduced in the early posttransplant period on survival, graft function, and renal function. We aimed to review LTRs who developed AKI requiring CRRT postoperatively and followed their long-term outcomes at Tohoku University Hospital (TUH).
methodsMedical records of consecutive patients who underwent LTx at TUH between 2000 and 2018 were reviewed, with follow-up to 2019 inclusive.
resultsAlthough mortality in those who required CRRT (n = 21) was increased versus those who did not require CRRT (n = 85)(
conclusionsThe initiation of CRRT posttransplant may be a useful strategy to preserve cardiac and optimize volume management among critically ill patients.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.